117 related articles for article (PubMed ID: 31460256)
1. First Insight on Small Molecules as Cardiac Calsequestrin Stabilizers.
Chakravarty H; Bal C; Yadav M; Jena N; Bal NC; Sharon A
ACS Omega; 2019 Jul; 4(7):11508-11514. PubMed ID: 31460256
[TBL] [Abstract][Full Text] [Related]
2. The catecholaminergic polymorphic ventricular tachycardia mutation R33Q disrupts the N-terminal structural motif that regulates reversible calsequestrin polymerization.
Bal NC; Sharon A; Gupta SC; Jena N; Shaikh S; Gyorke S; Periasamy M
J Biol Chem; 2010 May; 285(22):17188-96. PubMed ID: 20353949
[TBL] [Abstract][Full Text] [Related]
3. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
[TBL] [Abstract][Full Text] [Related]
4. Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT).
Eckey K; Strutz-Seebohm N; Katz G; Fuhrmann G; Henrion U; Pott L; Linke WA; Arad M; Lang F; Seebohm G
Cell Physiol Biochem; 2010; 26(4-5):503-12. PubMed ID: 21063088
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes.
Kubalova Z; Györke I; Terentyeva R; Viatchenko-Karpinski S; Terentyev D; Williams SC; Györke S
J Physiol; 2004 Dec; 561(Pt 2):515-24. PubMed ID: 15486014
[TBL] [Abstract][Full Text] [Related]
6. Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT.
Liu B; Ho HT; Brunello L; Unudurthi SD; Lou Q; Belevych AE; Qian L; Kim DH; Cho C; Janssen PM; Hund TJ; Knollmann BC; Kranias EG; Györke S
Cardiovasc Res; 2015 Nov; 108(2):299-311. PubMed ID: 26410369
[TBL] [Abstract][Full Text] [Related]
7. Probing cationic selectivity of cardiac calsequestrin and its CPVT mutants.
Bal NC; Jena N; Sopariwala D; Balaraju T; Shaikh S; Bal C; Sharon A; Gyorke S; Periasamy M
Biochem J; 2011 Apr; 435(2):391-9. PubMed ID: 21265816
[TBL] [Abstract][Full Text] [Related]
8. Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models.
Kurtzwald-Josefson E; Yadin D; Harun-Khun S; Waldman M; Aravot D; Shainberg A; Eldar M; Hochhauser E; Arad M
Heart Rhythm; 2017 Jul; 14(7):1053-1060. PubMed ID: 28336343
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis reveals splicing mutations of the CASQ2 gene in patients with CPVT: implication for genetic counselling and clinical management.
Roux-Buisson N; Rendu J; Denjoy I; Guicheney P; Goldenberg A; David N; Faivre L; Barthez O; Danieli GA; Marty I; Lunardi J; Fauré J
Hum Mutat; 2011 Sep; 32(9):995-9. PubMed ID: 21618644
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the first induced pluripotent stem cell line generated from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia due to a heterozygous mutation in cardiac calsequestrin-2.
Ross S; Holliday M; Lim S; Semsarian C
Stem Cell Res; 2019 May; 37():101450. PubMed ID: 31039485
[TBL] [Abstract][Full Text] [Related]
11. Left Cardiac Sympathetic Denervation in Patients with CASQ2-Associated Catecholaminergic Polymorphic Ventricular Tachycardia.
Marai I; Boulos M; Khoury A
Isr Med Assoc J; 2015 Sep; 17(9):538-40. PubMed ID: 26625541
[TBL] [Abstract][Full Text] [Related]
12. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia.
Postma AV; Denjoy I; Hoorntje TM; Lupoglazoff JM; Da Costa A; Sebillon P; Mannens MM; Wilde AA; Guicheney P
Circ Res; 2002 Oct; 91(8):e21-6. PubMed ID: 12386154
[TBL] [Abstract][Full Text] [Related]
13. Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: a simulation study of cellular mechanism.
Faber GM; Rudy Y
Cardiovasc Res; 2007 Jul; 75(1):79-88. PubMed ID: 17531962
[TBL] [Abstract][Full Text] [Related]
14. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
Laitinen PJ; Swan H; Kontula K
Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276
[TBL] [Abstract][Full Text] [Related]
16. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.
de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A
Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293
[TBL] [Abstract][Full Text] [Related]
17. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
[TBL] [Abstract][Full Text] [Related]
18. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
Dirksen WP; Lacombe VA; Chi M; Kalyanasundaram A; Viatchenko-Karpinski S; Terentyev D; Zhou Z; Vedamoorthyrao S; Li N; Chiamvimonvat N; Carnes CA; Franzini-Armstrong C; Györke S; Periasamy M
Cardiovasc Res; 2007 Jul; 75(1):69-78. PubMed ID: 17449018
[TBL] [Abstract][Full Text] [Related]
19. [A Novel mutation of F189L in CASQ2 in families with catecholaminergic polymorphic ventricular tachycardia].
Liu QQ; Oberti C; Zhang XQ; Ke T; Zhang T; Scheinman M; Hu DY; Wang QK
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):334-7. PubMed ID: 18543230
[TBL] [Abstract][Full Text] [Related]
20. Current topics in catecholaminergic polymorphic ventricular tachycardia.
Sumitomo N
J Arrhythm; 2016 Oct; 32(5):344-351. PubMed ID: 27761157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
